View the poster here. Share this:Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Like this:Like Loading...
4 thoughts on “P36 – Gill”
Hey Kiara! I was wondering what some of the limitations you encountered were?
Temperate phages lack the potency of lytic phages, why would they still be considered for use in phage therapy? I know environmental disruption can induce the lytic cycle in a temperate phage. Is there a way to achieve this in phage therapy without harming the host cell?
Once research has been expanded to include temperate phages, how could your specific phage be considered more successful in helping to make antibiotics obsolete?
I thought you did a very nice job explaining your poster! Were the results of your experiment similar to your expected outcomes before starting the experiment? And in relation to that, did you face any challenges in this research that may have skewed your results?